CPC A61K 31/717 (2013.01) [A61K 31/704 (2013.01); A61L 15/28 (2013.01); A61L 15/44 (2013.01); A61L 24/0015 (2013.01); A61L 24/0042 (2013.01); A61L 24/08 (2013.01); A61L 2400/04 (2013.01)] | 3 Claims |
1. A method of enhancing a destructive, inhibitive, and/or lethal effect of a glycolytic dependent compound towards cancerous cells in a tissue and/or organ in a subject, the method comprising the steps of:
A—targeting the glycolytic dependent compound to the cancerous tissue and/or organ by placing oxidized regenerated cellulose (ORC) and/or oxidized cellulose (OC) in direct connection with one or more cancerous cells in the tissue and/or organ, and
B—administering the glycolytic dependent compound to the subject by a systemic route,
wherein the ORC and/or OC and the glycolytic dependent compound are administered by different administration routes, and wherein the destructive, inhibitive, and/or lethal effect is enhanced as compared to a same dose of the glycolytic dependent compound administered in the absence of ORC/OC contact.
|